Cargando…
Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
An estimated one quarter of persons worldwide are infected with Mycobacterium tuberculosis. In 2018, the World Health Organization issued revised guidance on BCG vaccine for high-risk groups. The World Health Organization should consider guiding countries on a case-by-case basis in developing approp...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045831/ https://www.ncbi.nlm.nih.gov/pubmed/31922950 http://dx.doi.org/10.3201/eid2603.191232 |
_version_ | 1783501853291446272 |
---|---|
author | Pooransingh, Shalini Sakhamuri, Sateesh |
author_facet | Pooransingh, Shalini Sakhamuri, Sateesh |
author_sort | Pooransingh, Shalini |
collection | PubMed |
description | An estimated one quarter of persons worldwide are infected with Mycobacterium tuberculosis. In 2018, the World Health Organization issued revised guidance on BCG vaccine for high-risk groups. The World Health Organization should consider guiding countries on a case-by-case basis in developing appropriate BCG policies to deliver equitable healthcare and protect public health. |
format | Online Article Text |
id | pubmed-7045831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-70458312020-03-07 Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations Pooransingh, Shalini Sakhamuri, Sateesh Emerg Infect Dis Research Letter An estimated one quarter of persons worldwide are infected with Mycobacterium tuberculosis. In 2018, the World Health Organization issued revised guidance on BCG vaccine for high-risk groups. The World Health Organization should consider guiding countries on a case-by-case basis in developing appropriate BCG policies to deliver equitable healthcare and protect public health. Centers for Disease Control and Prevention 2020-03 /pmc/articles/PMC7045831/ /pubmed/31922950 http://dx.doi.org/10.3201/eid2603.191232 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Letter Pooransingh, Shalini Sakhamuri, Sateesh Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title | Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title_full | Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title_fullStr | Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title_full_unstemmed | Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title_short | Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations |
title_sort | need for bcg vaccination to prevent tb in high-incidence countries and populations |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045831/ https://www.ncbi.nlm.nih.gov/pubmed/31922950 http://dx.doi.org/10.3201/eid2603.191232 |
work_keys_str_mv | AT pooransinghshalini needforbcgvaccinationtopreventtbinhighincidencecountriesandpopulations AT sakhamurisateesh needforbcgvaccinationtopreventtbinhighincidencecountriesandpopulations |